10 research outputs found
Clinical features and management of oral lichen planus (OLP) with emphasis on the management of hepatitis C virus (HCV)-related OLP
Oral lichen planus (OLP) is a chronic inflammatory disease characterized by the occurrence of multiple, symmetrical lesions in the oral cavity. Hepatitis C virus (HCV) infection has been suggested as an etiological factor in OLP. The purpose of this review was to summarize the current literature regarding the treatment of OLP in patients with HCV infection. An electronic search of the PubMed database was conducted until January 2018, using the following keywords: OLP, HCV, corticosteroids, retinoids, immunomodulatory agents, surgical interventions, photochemotherapy, laser therapy, interferon, ribavirin, and direct-acting antivirals. We selected the articles focusing on the clinical features and treatment management of OLP in patients with/without HCV infection. Topical corticosteroids are considered the first-line treatment in OLP. Calcineurin inhibitors or retinoids can be beneficial for recalcitrant OLP lesions. Systemic therapy should be used in the case of extensive and refractory lesions that involve extraoral sites. Surgical intervention is recommended for isolated lesions. In patients with HCV, monotherapy with interferon (IFN)-α may either improve, aggravate or trigger OLP lesions, while combined IFN-α and ribavirin therapy does not significantly influence the progression of lesions. Direct-acting antiviral (DAA) therapy appears to be a promising approach in patients with HCV-related OLP, as it can improve symptoms of both liver disease and OLP, with fewer side effects. Nevertheless, for clinical utility of DAAs in OLP patients, further studies with larger sample sizes, adequate treatment duration, and long term follow-up are required
Alendronate Prevents Early Periprosthetic Bone Loss in Cementless Total Hip Arthroplasty Better Than Simvastatin
Background and Objectives: Cementless total hip arthroplasty leads to an early periprosthetic bone loss, which can impair the osseointegration process and lead to a femoral implant migration during early weight-bearing. An altered osseointegration process can lead to aseptic loosening, which is the most frequent late complication in these surgical procedures. The objective of this study was to compare the effect of alendronate and simvastatin in the prevention of early periprosthetic bone loss found in osteoporotic patients. This can lead to earlier weight-bearing in patients, as well as reduce the rate of aseptic loosening. Materials and Methods: Forty-five patients undergoing cementless total hip arthroplasty were equally distributed into three groups: group I (alendronate), group II (simvastatin), and group III (control). The alendronate group received 5 mg of alendronate postoperatively, daily for 8 weeks, and the simvastatin group received 20 mg daily for 4 weeks postoperatively, followed by 40 mg daily for 4 weeks. We determined bone mineral density (BMD), as well as bone serum markers beta cross-laps (β-CTx) and alkaline phosphatase (ALPL) preoperatively, 4 weeks postoperatively, and 8 weeks postoperatively. All patients were not allowed to fully bear weight for 6 weeks postoperatively. Results: Alendronate statistically significantly increases the BMD at one month postoperatively compared to the control group in Gruen zones 5 and 6 (p = 0.042 and p = 0.039). Overall, the BMD was higher in the alendronate group compared to the control group at one month postoperatively (p = 0.043). Alendronate decreased β-CTx bone serum marker compared to control at one month and two months (p = 0.024 and p = 0.012). Moreover, alendronate showed a higher decrease in β-CTx compared to simvastatin at both timelines (p = 0.028 and p = 0.03, respectively). Conclusions: The study shows that alendronate administration following cementless total hip arthroplasty offers better protection against periprosthetic bone loss compared to simvastatin
Custom-Made 3D-Printed Prosthesis after Resection of a Voluminous Giant Cell Tumour Recurrence in Pelvis
Abstract: Giant-cell tumours are benign aggressive bone lesions that can affect any part of the skeleton. In early stages, curettage is preferred, but in case of local recurrence or voluminous lesions in the periacetabular region, wide resection and reconstruction are recommended. The purpose of this article is to increase clinicians’ awareness of the importance of the follow-up of these patients and to describe a case of a voluminous recurrence of a giant-cell tumour in the pelvis. We present a 25-year-old female who underwent internal hemipelvectomy assisted by 3D cutting-guides and reconstruction with a custom-made 3D-printed pelvic prosthesis, hip arthroplasty and ilio-sacral arthrodesis. No postoperative complications occurred and, at long-term follow-up, the patient had a stable and painless hip joint, good bone-implant osteointegration, with an excellent functional outcome. In spite of all available reconstructive techniques, in well-selected patients with voluminous pelvic resections, custom-made 3D-printed implants allow patients to have a good mechanical outcome
Custom-Made 3D-Printed Prosthesis after Resection of a Voluminous Giant Cell Tumour Recurrence in Pelvis
Abstract: Giant-cell tumours are benign aggressive bone lesions that can affect any part of the skeleton. In early stages, curettage is preferred, but in case of local recurrence or voluminous lesions in the periacetabular region, wide resection and reconstruction are recommended. The purpose of this article is to increase clinicians’ awareness of the importance of the follow-up of these patients and to describe a case of a voluminous recurrence of a giant-cell tumour in the pelvis. We present a 25-year-old female who underwent internal hemipelvectomy assisted by 3D cutting-guides and reconstruction with a custom-made 3D-printed pelvic prosthesis, hip arthroplasty and ilio-sacral arthrodesis. No postoperative complications occurred and, at long-term follow-up, the patient had a stable and painless hip joint, good bone-implant osteointegration, with an excellent functional outcome. In spite of all available reconstructive techniques, in well-selected patients with voluminous pelvic resections, custom-made 3D-printed implants allow patients to have a good mechanical outcome
Atelo-collagen type I bovine bone substitute and membrane in guided bone regeneration: a series of clinical cases and histopathological assessments
Absorbable atelo-collagen type 1 represents a
new approach for guided bone regeneration with several
reported advantages such as: osteoblast attachment,
proliferation, mineralization potential, absorption of
growth factors and inhibition of bacterial pathogen
colonization. The aim of this study was to assess the
clinical, radiological (preoperative width, re-entry width,
gain), Periotest measurements and histologic benefits of
atelo-collagen-derived bovine bone grafts (ImploBone)
in combination with an atelo-collagen type I barrier
membrane (ImploSorb) for guided bone regeneration
(GBR) of atrophic alveolar crest in thirteen patients.
Eleven patients underwent simultaneous GBR with
implant insertion, two had initial GBR procedure
followed by implant placement after 6 months of
healing. Ridge augmentation was performed using an
atelo-collagen membrane (ImploSorb, Bioimplon,
Germany) and a combination of 50% ABBM
(ImploBone, granule size 0.5-1mm, BioImplon
Germany) mixed with 50% autologous bone.
It was found that simultaneous GBR with implant
placement resulted in a 35% gain at bone defect level
(preoperative width 5.03±1.25 mm, re-entry width
6.81±0.98 mm, gain 1.78±1.71 mm). Implant placement
performed in a 2 stage surgery 6 months following GBR
was linked with a 63.9% gain at bone defect level
(preoperative width 3.79±1.10 mm, re-entry width
6.22±1.41 mm, gain 2.43±1.43 mm). The total gain in
both groups was 41.9% utilizing these novel
biomaterials (preoperative width 4.68±1.32 mm, re-entry
width 6.65±1.12 mm, gain 1.96±1.64 mm).
This case series study presents a protocol where
GBR can be performed either simultaneously to implant
placement or delayed with this innovative biomaterial to
favor bone regrowth. Future randomized controlled
clinical trials are needed to further validate the bonepromoting potential of atelo-collagen-based biomaterials
for bone regeneration
STATISTICAL STUDY ON THE PREVALENCE OF DENTAL LESIONS OF THE ANTERIOR SEGMENT OF THE DENTAL ARCHES AND THE CALL FOR TREATMENT FOR THESE LESIONS –PART 1
The work performed within Clinical Base of the Gr. T. Popa U.M.P., Faculty of Dental Medicine Iași, has a number of objectives the materialization of which brings forth a new trend of dental medicine, towards a properly coordinated prophylaxis focused on the real needs of the population.The purpose of the study commencement consists in: evaluation of population’s oral health, on categories and age groups; determination of the local factor impact on health; assessment of dental care usage level in Moldova region; provision of statistical data regarding the oral health of the population in Romania; implementation of evaluation systems and of the data processing standard, in order to achieve oral health programs. A clinical record to contain data regarding the following section was created: environmental factors, anthropology, general condition of the body, prophylaxis, dental medicine. The study was conducted on a batch consisting of 646 patients from various social backgrounds and age categories, of which, a batch with age between 18-50 was selected. We deem the presentation of distribution according to age and sex of the whole batch, interesting. For a clearer vision, we considered a 5 to 10 year range. Our purpose, in this study, was to emphasize the extent of damage in the investigated population comprising patients aged between 18 and 50, the batch size and study scale allowing us to conclude that there are well defined clinical entities in the sphere of oral pathology. The clinical circumstance represented by lesions and existing treatments is dominant in the upper front group by the existing fillings and fixed prosthetics
Low-Molecular-Weight Heparins (LMWH) and Synthetic Factor X Inhibitors Can Impair the Osseointegration Process of a Titanium Implant in an Interventional Animal Study
Background and objectives: Cementless total hip arthroplasty is a common surgical procedure and perioperative thromboprophylaxis is used to prevent deep vein thrombosis or pulmonary embolism. Osseointegration is important for long-term implant survival, and there is no research on the effect of different thromboprophylaxis agents on the process of osseointegration. Materials and Methods: Seventy rats were allocated as follows: Group I (control group), Group II (enoxaparin), Group III (nadroparin), and Group IV (fondaparinux). Ovariectomy was performed on all subjects, followed by the introduction of an intramedullary titanium implant into the femur. Thromboprophylaxis was administered accordingly to each treatment group for 35 days postoperatively. Results: Group I had statistically significantly lower anti-Xa levels compared to treatment groups. Micro-CT analysis showed that nadroparin had lower values compared to control in bone volume (0.12 vs. 0.21, p = 0.01) and percent bone volume (1.46 vs. 1.93, p = 0.047). The pull-out test showed statistically significant differences between the control group (8.81 N) compared to enoxaparin, nadroparin, and fondaparinux groups (4.53 N, 4 N and 4.07 N, respectively). Nadroparin had a lower histological cortical bone tissue and a higher width of fibrous tissue (27.49 μm and 86.9 μm) at the peri-implant area, compared to control (43.2 μm and 39.2 μm), enoxaparin (39.6 μm and 24 μm), and fondaparinux (36.2 μm and 32.7 μm). Conclusions: Short-term administration of enoxaparin, nadroparin, and fondaparinux can reduce the osseointegration of titanium implants, with nadroparin having the most negative effect. These results show that enoxaparin and fondaparinux are preferred to be administered due to a lesser negative impact on the initial implant fixation